Medikay Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.20 M
as on 10-12-2024
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.20 M
as on 10-12-2024
- Revenue 29.34%
(FY 2017)
- Profit -47.65%
(FY 2017)
- Ebitda 7.83%
(FY 2017)
- Net Worth 3.16%
(FY 2017)
- Total Assets 49.87%
(FY 2017)
About Medikay Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹0.20 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rekha Bansal and Vir Bansal serve as directors at the Company.
- CIN/LLPIN
U74899DL1989PTC034652
- Company No.
034652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medikay Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Bansal  | Director | 13-Jan-1989 | Current |
| Vir Bansal | Director | 13-Jan-1989 | Current |
Financial Performance of Medikay Pharma.
Medikay Pharma Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 29.34% increase. The company also saw a substantial fall in profitability, with a 47.65% decrease in profit. The company's net worth moved up by a moderate rise of 3.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medikay Pharma?
In 2017, Medikay Pharma had a promoter holding of 36.57% and a public holding of 63.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Jan 2003 | ₹0.20 M | Satisfied |
How Many Employees Work at Medikay Pharma?
Unlock and access historical data on people associated with Medikay Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medikay Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medikay Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
